Collplant生物技术 CLGN 深 沪
已收盘 02-06 16:00:00 美东时间
0.7999
+0.050
+6.65%
华盛通- 最 高0.83
- 今 开0.83
- 成交量 29.06万股
- 最 低 0.68
- 昨 收 0.75
- 总市值 1021.98万
- 52周最高 4.98
- 市盈率 静 --
- 换手率 2.27%
- 52周最低 0.6599
- 委 比 -62.75%
- 总股本 1277.64万
- 历史最高 24.26
- 量 比 1.58
- 振 幅 20.00%
- 历史最低 0.6599
- 每 手 1
- 风险率 0.63%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多This Impinj Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Friday
Top Wall Street analysts changed their outlook on these top names. For a comple...
02-06 22:35
D. Boral Capital Downgrades CollPlant Biotechnologies to Hold
D. Boral Capital analyst Jason Kolbert downgrades CollPlant Biotechnologies (NASDAQ:CLGN) from Buy to Hold.
02-06 20:57
CollPlant To Issue 1.6M Shares And Warrants In $2M Offering To Support R&D And Corporate Growth
CollPlant Biotechnologies (NASDAQ:CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived, rhCollagen for tissue regeneration and medical
02-05 21:16
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING
REHOVOT, Israel, Feb. 5, 2026 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based o...
02-05 21:00
美股大行评级 | 美银证券下调哔哩哔哩目标价至31美元；高盛下调诺和诺德目标价至54美元
今日重点评级关注：Benchmark：维持Grupo Televisa"买入"评级，目标价从9美元升至10美元；Truist Securities：维持迪尔股份"买入"评级，目标价从609美元升至612美元
2025-12-01 14:33
D. Boral Capital Maintains Buy on CollPlant Biotechnologies, Maintains $12 Price Target
D. Boral Capital analyst Jason Kolbert maintains CollPlant Biotechnologies (NASDAQ:CLGN) with a Buy and maintains $12 price target.
2025-11-28 22:06
CollPlant Biotechnologies shares are trading lower after the company reported worse-than-expected Q3 financial results.
CollPlant Biotechnologies shares are trading lower after the company reported w...
2025-11-26 22:00
CollPlant Biotechnologies Q3 Adj. EPS $(0.25) Misses $0.15 Estimate, Sales $77.000K Miss $4.845M Estimate
CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $0.15 by 261.29 percent. This is a 24.24 percent increase over losses of $(0.33) per
2025-11-26 20:43
Earnings Scheduled For November 26, 2025
Companies Reporting Before The Bell • Deere (NYSE:DE) is estimated to report qu...
2025-11-26 19:11
